Cannabis Stocks - Watchlist

So many to choose from. Any opinions on the top 2 or 3 picks from that lot? QBL has had some strong gains in the last week or so.
 
For me MXC, CPH and the overlooked BOT.
Have been holding all from the start and trading MXC on the dips.
 
tbh, I haven't done extensive FA research on many of them. They vary greatly in activities and progress. Some focused largely on research. I have traded some in the past (mostly based on charts) like ZLD & AC8 and recently sold MXC.

CAN's recent A$60 mill cap raise was quite significant. I think its probably the clear market leader now.

Just be cautious when interest (volume) dries up in spec end of market again. ie. look at Cannabis stocks back in Feb-March, followed by the huge pullbacks they experienced.
 
CAN's CR is huge at $60 mill. It eclipses just about all the other raises. The question is whether to participate in the SPP? I bought at 60 cents soon after listing, sold half for $1.20, so I'm free-carried. Will see how the share price trades after resuming and will decide whether to jump back in or just arbitrage the SPP.

Another company to watch is Elixinol, which will list soon with a very tight register. No public offer, so only available with broker relationships. It is an industrial and food hemp company with revenues looking to break into the medicinal side as well. Most similar comparison would be QBL's MCL holding, but more advanced by the looks with their US company.
 
Got tipped to MXC just on two months back, took a look but Waay to many shares on the register for what they are floating as a viable business model.
 
CPH went TH till next week
Feeling it is a good vibe coming soon.....
Current SP below their recent CR.
 
Brendio said:
CAN's CR is huge at $60 mill. It eclipses just about all the other raises. The question is whether to participate in the SPP? I bought at 60 cents soon after listing, sold half for $1.20, so I'm free-carried. Will see how the share price trades after resuming and will decide whether to jump back in or just arbitrage the SPP.

Another company to watch is Elixinol, which will list soon with a very tight register. No public offer, so only available with broker relationships. It is an industrial and food hemp company with revenues looking to break into the medicinal side as well. Most similar comparison would be QBL's MCL holding, but more advanced by the looks with their US company.
Click to expand...

Saw this, a good buy since SP now close to CR? Hoping to buy at lower than $2.50 ☺️
 
ASX cannabis stocks finishing very strong today. Many closing at all new highs. ASX finally woken up to what has been happening to cannabis stocks in the US/Canadian cannabis (and ETFs) which have been going parabolic for the last few weeks.

Total ASX cannabis stock mkt cap up 24.8% in 1 day to total over A$2bn for first time.

DSrQYY4VoAA_Ve4.jpg


Visualisations comparing sector market caps (plus overall cannabis sector maket cap):
DSrQXXLVMAA0CBr.jpg

DSrQXWoU0AA8uhE.jpg
 
Last edited:
Announcement of the legalisation of cannabis exports. It opens up the market for AU companies to the world.
 
Wow the ASX listed stocks are going amazingly well. MMJ, MXC, AC8, ZLD, CAN all solid performers. Is this a short term thing - or will the export markets opening up lead to bigger and better things for these companies? Most have varying products developed ready for the market. I am excited at the prospect of an alternate analgesic agent instead of the opiate based drugs (Like Oxycontin) - It worries me the number of people out there on incredible cocktails of opiates, sedatives. anti-depressants, anticonvulsants and neuropathic pain meds. Offers a real alternative for many patients and will be an interesting few years to see how this space develops with real impetus for high quality research in this field.
 
QLB went TH. Joining with a Canadian company for meds. QBL is vertically integrated from farm to retail with processing for themselves and other hemp companies. Backed by a Queensland miner. Smart board members. When trading resumes expected to triple in value.
 
Becareful on the short term, Sessions is making noises about cannabis.

US might change tack on it. Doesn’t mean Australian pharma will be devastated but the forecast might not be the same.
 
BOT getting some very good trial results and continues to climb. As said several times before, this is one to watch.
 
Cannabis - Nth American cannabis stocks coming down hard from their 'highs'....

Nth American Marijuana Index (equal weighting Index)
marijuana_index_4feb2018.png


HMMJ:
hmmj_4feb2018.png


MJX:
mjx_4feb2018.png


These Cannabis ETFs were a leading indicator in late December before many of the ASX cannabis stocks took off in early Jan. Will be interesting to see how the ASX cannabis stocks will go in the short-term.
 
We'll, BOT have a whole lot of nothing now. Nothing they have has any statistical difference to the controls.
This is the start of the end of BOT
 
for the cannabis stocks, do they pay dividends in grams of leaves lol ?
 
You must log in or register to reply here.
Back
Top